Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weikang Ling Capsules is a traditional Chinese medicine (TCM) product manufactured by Sichuan Good Doctor Panxi Pharmaceutical. It is indicated for the treatment of various gastric conditions, including chronic gastritis, gastric ulcers, and duodenal ulcers. The formulation typically consists of a combination of herbal ingredients such as *Paeonia lactiflora*, *Glycyrrhiza uralensis*, *Poria cocos*, *Corydalis yanhusuo*, *Bletilla striata*, *Atractylodes macrocephala*, and *Panax notoginseng*, often supplemented with *Atropa belladonna* extract. The drug functions by providing analgesic and anti-inflammatory effects, reducing gastric acid secretion through the anticholinergic activity of the belladonna component, and promoting the repair and protection of the gastric mucosa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weikang Ling Capsules.